PTEN Protein (Phosphatase and Tensin Homolog)

PTEN Protein (Phosphatase and Tensin Homolog)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PTEN Protein (Phosphatase and Tensin Homolog)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">VO-OHpic</td>
<td>Catalytic inhibition</td>
</tr>
<tr>
<td class="label">BP-1-102</td>
<td>Allosteric targeting</td>
</tr>
<tr>
<td class="label">SAHA</td>
<td>HDAC inhibition + PTEN</td>
</tr>
<tr>
<td class="label">antisense oligonucleotides</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">CRISPR/dCas9</td>
<td>Epigenetic modulation</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">[PI3K](/proteins/pi3k-protein)</td>
<td>Substrate/regulator</td>
</tr>
<tr>
<td class="label">[Akt1](/proteins/akt1-protein)</td>
<td>Downstream kinase</td>
</tr>
<tr>
<td class="label">[mTOR](/proteins/mtor-protein)</td>
<td>Pathway target</td>
</tr>
<tr>
<td class="label">[GSK-3β](/proteins/gsk3b-protein)</td>
<td>Downstream kinase</td>
</tr>
<tr>
<td class="label">[BAD](/proteins/bad-protein)</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">[P53](/proteins/p53-protein)</td>
<td>Transcriptional</td>
</tr>
<tr>
<td class="label">[MAGI2](/proteins/magi2-protein)</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">[Cav-1](/proteins/cav1-protein)</td>
<td>Membrane

PTEN Protein (Phosphatase and Tensin Homolog)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PTEN Protein (Phosphatase and Tensin Homolog)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">VO-OHpic</td>
<td>Catalytic inhibition</td>
</tr>
<tr>
<td class="label">BP-1-102</td>
<td>Allosteric targeting</td>
</tr>
<tr>
<td class="label">SAHA</td>
<td>HDAC inhibition + PTEN</td>
</tr>
<tr>
<td class="label">antisense oligonucleotides</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">CRISPR/dCas9</td>
<td>Epigenetic modulation</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">[PI3K](/proteins/pi3k-protein)</td>
<td>Substrate/regulator</td>
</tr>
<tr>
<td class="label">[Akt1](/proteins/akt1-protein)</td>
<td>Downstream kinase</td>
</tr>
<tr>
<td class="label">[mTOR](/proteins/mtor-protein)</td>
<td>Pathway target</td>
</tr>
<tr>
<td class="label">[GSK-3β](/proteins/gsk3b-protein)</td>
<td>Downstream kinase</td>
</tr>
<tr>
<td class="label">[BAD](/proteins/bad-protein)</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">[P53](/proteins/p53-protein)</td>
<td>Transcriptional</td>
</tr>
<tr>
<td class="label">[MAGI2](/proteins/magi2-protein)</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">[Cav-1](/proteins/cav1-protein)</td>
<td>Membrane microdomains</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

PTEN (Phosphatase and Tensin Homolog) is a dual-specificity phosphatase that functions as a major negative regulator of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway. Originally characterized as a tumor suppressor, PTEN has emerged as a critical regulator of neuronal survival, synaptic plasticity, metabolism, and brain aging. In the nervous system, PTEN modulates cell survival pathways, controls dendritic spine morphology, and regulates autophagy — all processes central to neurodegenerative disease pathogenesis.

.infobox-protein
!! colspan="2" style="background:#f8f9fa; text-align:center; font-weight:bold" | PTEN Protein
|- [@stambolic1998]
! Gene
| [PTEN](/genes/pten)
|- [@hauser2019]
! UniProt
| [P60484](https://www.uniprot.org/uniprot/P60484)
|-
! PDB Structures
| 1D5R, 1D5T, 2KOB, 5O2D, 5W7V, 6GJQ
|-
! Molecular Weight
| ~47 kDa (403 amino acids)
|-
! Subcellular Localization
| Cytoplasm, nucleus, plasma membrane
|-
! Protein Family
| Phosphatase (Lipid/Protein dual-specificity)
|-

Structure and Domain Architecture

The PTEN protein contains several well-defined functional domains:

N-Terminal Phosphatase Domain (1-185)

The catalytic phosphatase domain contains the signature HCXXGXR motif:

• Active site: Cys124 is the catalytic nucleophile
• Phosphatase core: HCKDIG motif essential for activity
• WPD loop: Contains Asp92, important for catalysis
• Active site cover: Regulates substrate access

C2 Domain (186-351)

The C2 domain mediates membrane association:

• Membrane targeting: Binds phospholipid membranes
• Calcium independence: Unusual for C2 domains
• Phospholipid binding: Prefers PIP2-rich membranes
• Catalytic regulation: Links membrane association to activity

C-Terminal Tail (352-403)

The regulatory tail contains multiple features:

• Phosphorylation sites: Ser380, Thr382, Ser385 (C-terminal tail)
• PDZ binding motif: PDZ domain interaction (Val-Ala-Ile)
• Regulation by phosphorylation: Phosphorylation reduces activity
• Protein interactions: Scaffold for signaling complexes

Structural Features

Key structural elements include:

• P-loop: Phosphate-binding loop (residues 26-33)
• TIR loop: Variable insert affecting substrate specificity
• Catalytic loop: Contains the essential catalytic Asp
• RB loop: Interacts with phosphate groups

Normal Neuronal Function

PI3K/Akt Pathway Regulation

PTEN is the primary negative regulator of PI3K/Akt signaling in neurons:

• PIP3 dephosphorylation: Converts PIP3 to PIP2
• Akt membrane recruitment: Prevents Akt phosphorylation
• mTORC1 inhibition: Blocks protein synthesis signaling
• Cell survival modulation: Regulates BAD, caspase-9 activity

Neuronal Survival

PTEN regulates neuronal survival through multiple mechanisms:

• BAD phosphorylation: Akt phosphorylates BAD, promoting survival
• Caspase inhibition: Blocks caspase-9 activation
• Forkhead transcription: Prevents pro-apoptotic gene expression
• Autophagy regulation: Controls autophagosome formation

Synaptic Plasticity

PTEN critically modulates synaptic function:

• AMPA receptor trafficking: Regulates synaptic strength
• Dendritic spine morphology: Controls spine size and number
• Long-term potentiation (LTP): Essential for memory formation
• Long-term depression (LTD): Modulates synaptic weakening
• mTOR signaling: Controls local protein synthesis

Neural Development

During brain development, PTEN:

• Regulates neural progenitor cell proliferation
• Controls neuronal differentiation
• Guides axon pathfinding
• Modulates dendrite morphogenesis
• Mediates synapse formation

Role in Alzheimer's Disease

PTEN is significantly implicated in AD pathogenesis through multiple mechanisms:

Amyloid-Beta Effects

• Aβ-induced PTEN activation: Exposure to Aβ increases PTEN expression
• Synaptic PTEN translocation: PTEN moves to synapses in response to Aβ
• Synaptic dysfunction: Synaptic PTEN contributes to memory deficits
• Excitotoxicity: PTEN enhances glutamate toxicity

Tau Pathology

• Akt/GSK-3β axis: PTEN regulates tau phosphorylation via Akt
• Tau-mediated sequestration: Pathological tau can sequester PTEN
• Therapeutic implications: PTEN inhibition protects against tauopathy

Therapeutic Strategies

Research Findings

• PTEN deletion enhances memory in AD mouse models
• Partial PTEN inhibition may be beneficial
• Activity-dependent neuronal PTEN regulation

Role in Parkinson's Disease

PTEN involvement in PD includes:

Dopaminergic Neuron Survival

• Elevated PTEN activity: Increased in PD models and patient brains
• MPTP toxicity: PTEN deletion protects dopaminergic neurons
• PI3K/Akt neuroprotection: Agonists show promise in PD models

Alpha-Synuclein Pathology

• Aggregation modulation: PTEN affects α-synuclein aggregation
• Autophagy dysregulation: Contributes to protein clearance deficits
• Mitochondrial function: Linked to PTEN-PI3K signaling

Mitochondrial Quality Control

• PINK1/Parkin pathway: PTEN intersects with mitophagy
• Metabolic dysfunction: Contributes to energy deficit
• Oxidative stress: Affects antioxidant responses

Therapeutic Potential

• PTEN inhibitors protect dopaminergic neurons
• Gene therapy approaches in development
• Combination with other neuroprotective strategies

Role in Amyotrophic Lateral Sclerosis (ALS)

In ALS, PTEN:

• Motor neuron vulnerability: PTEN levels altered in motor neurons
• TDP-43 pathology: Intersects with TDP-43 proteinopathy
• Excitotoxicity: Modulates glutamate toxicity
• Therapeutic potential: PTEN inhibition extends survival in models

Role in Other Neurological Disorders

Huntington's Disease

• Contributes to metabolic dysfunction
• Altered mTOR signaling
• Affected autophagy-lysosome pathway

Multiple Sclerosis

• Regulates oligodendrocyte survival
• Myelin maintenance functions
• Demyelination mechanisms

Stroke and Ischemia

• Mediates ischemic injury response
• PTEN deletion is neuroprotective
• Timing-dependent effects

Neurodevelopmental Disorders

• Germline PTEN mutations cause Cowden syndrome
• Contributes to autism spectrum disorders
• Intellectual disability phenotypes

Protein Interactions

PTEN interacts with key neuronal proteins:

Signaling Pathways

PTEN in Neuronal Survival

PTEN in Synaptic Plasticity

Brain Region Expression

PTEN exhibits region-specific expression:

Subcellular localization:

• Synaptic compartments: Pre- and post-synaptic
• Dendritic shafts: Throughout dendritic arbor
• Cell body: Cytoplasmic and nuclear
• Growth cones: Axonal guidance

Therapeutic Targeting

Challenges

• Systemic effects: PTEN is a tumor suppressor
• Safety concerns: Full inhibition causes cancer risk
• Brain penetration: Drug delivery challenges
• Therapeutic window: Balance between efficacy and safety

Strategies

Biomarkers

• Phospho-PTEN: Activation state in CSF
• PIP3 levels: Downstream readout
• Imaging: PET ligands under development

Research Models

Animal Models

• Neuron-specific PTEN knockout: Viable, enhanced memory
• Conditional deletion: Temporal control
• Point mutants: Catalytically dead versions

Cell Models

• Primary neurons: Cortical and hippocampal
• SH-SY5Y: Dopaminergic cell line
• Patient-derived iPSCs: Disease modeling

Key Publications

Cross-links

• [PTEN Gene](/genes/pten) — Gene page
• [Akt1 Protein](/proteins/akt1-protein) — Key effector
• [PI3K Protein](/proteins/pi3k-protein) — Upstream activator
• [mTOR Protein](/proteins/mtor-protein) — Downstream target
• [GSK-3β Protein](/proteins/gsk3b-protein) — Tau kinase
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease link
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease link
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Disease link

See Also

• [PI3K/Akt Signaling Pathway](/mechanisms/pi3k-akt-pathway)
• [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)
• [Neurodegeneration Mechanisms](/mechanisms)
• [Kinase/Phosphatase Biology](/)

References